Olema Pharmaceuticals, Inc. (OLMA): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

87.01M
Year ended 2025-12-31
+29.6%
3-year compound annual growth
+65.4%
5-year compound annual growth
2019-12-31: 2.59M2020-12-31: 7.02M2021-12-31: 39.52M2022-12-31: 40.00M2023-12-31: 45.25M2024-12-31: 58.74M2025-12-31: 87.01M87.01M
2019-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3187.01M+48.1%2026-03-16, From 2025-01-01
2024-12-3158.74M+29.8%2026-03-16, From 2024-01-01
2023-12-3145.25M+13.1%2025-03-18, From 2023-01-01
2022-12-3140.00M+1.2%2024-03-11, From 2022-01-01
2021-12-3139.52M+462.9%2023-03-09, From 2021-01-01
2020-12-317.02M+170.8%2022-02-28, From 2020-01-01
2019-12-312.59Mn/a2022-02-28, From 2019-01-01